Revolutionary breakthrough unveiled: The combination of antibody-drug conjugates and immune checkpoint blockade sheds new light on advanced urothelial carcinoma.

FU-JEN HSUEHYU CHIEH TSAI2024-12-062024-12-062024-12https://scholars.lib.ntu.edu.tw/handle/123456789/723613enRevolutionary breakthrough unveiled: The combination of antibody-drug conjugates and immune checkpoint blockade sheds new light on advanced urothelial carcinoma.journal article10.1016/j.jfma.2024.10.00639419721